Novartis

Novartis, GenVec to develop hearing-loss treatment in $214M deal
Bizjournals.com
Tue, 01/19/10 - 09:18 pm
hearing loss
Novartis
GenVec
partnerships
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tue, 01/19/10 - 09:40 am
Adventrx
Genentech
Novartis
Amgen
Pfizer
Novelos Therapeutics
ONYX Pharmaceuticals
Biotech's Latest Failed Trials, Mishaps and Missed Targets
Seeking Alpha
Mon, 01/18/10 - 12:07 pm
Pfizer
AstraZeneca
GSK
Ranbaxy
Novartis
Sanofi
Medicines Company
Charles River Laboratories
Novartis Invests Wisely in Smart Pill
Seeking Alpha
Mon, 01/18/10 - 11:57 am
Novartis
Proteus Biomedical
smart pills
GSK braced for low sales of flu drug
FT.com
Mon, 01/18/10 - 11:56 am
GSK
vaccines
H1N1
Novartis
Sanofi
That Novartis-Alcon Deal May Have a Tax Problem
WSJ Online
Thu, 01/14/10 - 04:10 pm
M&A
Alcon
Novartis
Alnylam Pharma Guides
Yahoo/Zacks.com
Thu, 01/14/10 - 10:17 am
Alnylam
guidance
Novartis
Biogen Idec
Competitive Schizophrenia Market
Yahoo/Zacks.com
Tue, 01/12/10 - 08:57 pm
schizophrenia
Eli Lilly
Novartis
Vanda
Zyprexa Relprevv
Fanapt
Novartis leads drug stocks lower
Marketwatch
Tue, 01/12/10 - 10:05 am
Novartis
drug stocks
Stocks to Watch at Biotech’s Bellwether Conference
Minyanville
Mon, 01/11/10 - 09:28 pm
Medtronic
Gilead Sciences
Human Genome
Novartis
GSK
Sangamo BioSciences
Indenix
Shareholders File Lawsuit Against Novartis & Alcon Over Merger -- KSF Announces Lawsuit
Yahoo
Mon, 01/11/10 - 04:22 pm
M&A
Alcon
Novartis
lawsuits
Johnson & Johnson: My First Pick of 2010
Seeking Alpha
Mon, 01/11/10 - 11:27 am
JNJ
Eli Lilly
Novartis
Amgen
Proctor & Gamble
Biogen Idec
Genzyme
Gilead Sciences
Teva Pharmaceuticals
King
Mylan
Pfizer
GSK
Sanofi
Abbott Laboratories
China's Vaccine Sector: How to Get in the Game
Seeking Alpha
Fri, 01/8/10 - 10:36 am
vaccines
China
Novartis
GSK
Pfizer
Merck
Sinovac
Novartis to Buy Aclon: Will the Gurus Sell?
Seeking Alpha
Thu, 01/7/10 - 10:02 am
Novartis
Alcon
M&A
Which Drugs Have The Biggest Pre-Tax Margins?
Pharmalot
Wed, 01/6/10 - 10:47 am
Pfizer
AstraZeneca
Novartis
Eli Lilly
Roche
Sanofi
Bristol-Myers Squibb
Vasella’s Persistence Pays Off as Novartis Gains Alcon’s Growth
Bloomberg
Wed, 01/6/10 - 08:42 am
Novartis
Pharma CEOs
Daniel Vasella
Alcon
M&A
FDA drug approvals mostly flat in 2009 as new leadership takes reins at agency
Yahoo/AP
Tue, 01/5/10 - 01:40 pm
FDA
drug approvals
Merck
GSK
Novartis
Novartis May Raise Bid to Appease Alcon Holders, Analysts Say
Bloomberg
Tue, 01/5/10 - 08:29 am
Novartis
Nestle
Alcon
M&A
Alcon: Novartis deal may hurt minority holders
Marketwatch
Tue, 01/5/10 - 06:46 am
Alcon
Novartis
M&A
Does Alcon Deal Stack Up For Novartis?
WSJ Online
Mon, 01/4/10 - 09:50 am
Alcon
Novartis
M&A

Pages